Market revenue in 2023 | USD 867.8 million |
Market revenue in 2030 | USD 1,223.4 million |
Growth rate | 5% (CAGR from 2023 to 2030) |
Largest segment | Frozen nondonor |
Fastest growing segment | Frozen Nondonor |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Fresh Nondonor, Frozen Nondonor, Fresh Donor, Frozen Donor |
Key market players worldwide | Bayer AG, Cook Medical, Merck KGaA, Ferring, FUJIFILM Holdings Corp, Genea Biomedx, Merck & Co Inc, The Cooper Companies Inc, Thermo Fisher Scientific Inc, Vitrolife AB ADR, Boston Scientific Corp, Nova IVF, Fortis Healthcare, RMA Network, TFP Fertility Group, US Fertility |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to in vitro fertilization market will help companies and investors design strategic landscapes.
Frozen nondonor was the largest segment with a revenue share of 48.24% in 2023. Horizon Databook has segmented the UK in vitro fertilization market based on fresh nondonor, frozen nondonor, fresh donor, frozen donor covering the revenue growth of each sub-segment from 2018 to 2030.
The demand for IVF treatments is expected to grow in the UK owing to the presence of several new government-approved techniques supporting the prevention of multiple births. The demand for IVF services continues to rise in the UK, with more individuals and couples seeking fertility treatments to overcome challenges related to infertility.
This can be attributed to factors such as delayed childbearing, increasing awareness & acceptance of IVF, and advancements in technology. The use of Preimplantation Genetic Testing (PGT) in IVF procedures is growing in the UK.
PGT allows the screening of embryos for genetic abnormalities before transfer, improving the chances of a successful pregnancy and reducing the risk of passing on genetic conditions. For instance, in May 2023, a pioneering IVF procedure referred to as Mitochondrial Donation Treatment (MDT) resulted in the birth of the first baby in the UK with DNA from three people.
Horizon Databook provides a detailed overview of country-level data and insights on the UK in vitro fertilization market , including forecasts for subscribers. This country databook contains high-level insights into UK in vitro fertilization market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account